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Effect of maternal treatment with PAHs on the ovarian follicle endowment in female offspring. (A) Morphological appearance of ovaries from 
3-week-old female daughters of mothers exposed to vehicle only (CC), PAH exposure (cumulative dose of 6 mg/kg) before pregnancy (PC), 
PAH exposure (cumulative dose of 6 mg/kg) during lactation (CP), and PAH exposure (cumulative dose of 12 mg/kg) both before pregnancy 
and during lactation exposure (PP). (B) Quantitative representation of the morphometric analysis of the ovarian pool for nonapoptotic oocyte-
containing primordial (resting) and primary (growing) follicles in different treatment groups is expressed as mean ± SEM. Each treatment group 
shown represents combined data obtained from at least 2 female offspring per litter from each treated mother: CC, n = 11; PC, n = 18; CP, n = 11; 
PP, n = 15. Effectiveness of AHR antagonist was assessed in mothers from the PP group supplemented with resveratrol (PPR), or mothers from 
the CC group (vehicle) supplemented with resveratrol (R) (cumulative dose of 120 mg/kg). Two to three females per litter from each mother were 
subjected to morphometric analysis (R, n = 6; PPR, n = 9). *P < 0.05 relative to control; **P < 0.05 relative to all treatment groups.
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PAH-driven Hrk induction and its functional requirement in regulation of ovarian pool. (A) Immunohistochemical analysis of Hrk protein (brown 
staining) in neonatal mouse ovaries following 24 hours of exposure to vehicle or 1 μM DMBA/BaP each during in vitro culture. Induction was 
observed in oocytes and granulosa cells of both primordial (black and white arrows) and primary follicles. Magnification, ×400. Hrk-deficient ovaries 
did not show upregulation of immunoreactivity in oocytes after PAH exposure, confirming the specificity of antibody. (B) Western blot analysis of 
neonate ovaries under the same conditions as described above. Upon adjustment to β-actin ratio, Hrk protein, migrating at approximately 15 kDa, 
was induced approximately 2.5-fold (P = 0.03). (C) Induction of Hrk transcript in in vitro–treated neonatal ovaries 24 hours after exposure to 
vehicle, 1 μM DMBA/BaP each (PAHs), treatment with PAH and 2 μM resveratrol (PAH/RSV), or 2 μM resveratrol alone (RSV). The expression 
data are shown as mean ± SEM of fold change in comparison with the vehicle-treated group and were obtained from 5 sets of independent ovaries 
per treatment. PAH induced significant (**P = 0.0006) upregulation of Hrk transcript, which was repressed by resveratrol treatment (*P = 0.005). 
RSV or RSV/PAH groups were not significantly different from vehicle-treated ovaries. (D) Ovaries from Hrk-deficient females were protected from 
PAH-induced depletion of primordial and primary follicles. Numerical representation of morphometric analysis of ovarian pool for nonapoptotic 
oocyte-containing primordial (resting) and primary (growing) follicles in sibling offspring born to heterozygote mothers exposed to PAHs prior to 
pregnancy and during lactation. Data are expressed as mean number of primordial and primary follicles ± SEM. Each genotype group represents 
combined data of offspring born to mothers exposed to vehicle (Hrk+/+, n = 5; Hrk–/–, n = 7) or treated with PAH (Hrk+/+, n = 4; Hrk–/–, n = 5). A sig-
nificant reduction of follicles was only observed in the wild-type ovaries (#P = 0.03; ##P = 0.05; NS, not significantly different).
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Ahr is involved in in vivo–induced follicle destruction in female offspring after maternal exposure to PAHs. (A) Schematic outline of putative XRE 
elements, identified by a MatInspector computer algorithm within 5,000 bp of murine Hrk promoter. (B) Ahr-deficient offspring born to mothers 
exposed to PAHs prior to pregnancy and during lactation retained a significantly larger primordial follicle pool than their wild-type sibling sisters. 
Quantitative representation of the morphometric analysis of the ovarian pool for nonapoptotic oocyte-containing primordial follicles is expressed 
as mean ± SEM. Each genotype group represents combined data from offspring born to mothers exposed to vehicle (Ahr+/+, n = 4; Ahr–/–, n = 3) or 
treated with PAH (Ahr+/+, n = 7; Ahr–/–, n = 3). A significant reduction of follicles was only observed in the wild-type ovaries (**P = 0.0003). (C) Ahr-
deficient neonatal ovaries failed to upregulate Hrk transcript expression in response to PAHs over a 24-hour period. The expression data are shown 
as fold change in PAH-treated ovary compared with vehicle-treated ovary from the same female (mean ± SEM) and were obtained from 4 sets of 
independent ovaries per treatment/genotype. PAH induced a significantly different response in wild-type and Ahr-deficient ovaries (P = 0.007). 
(D) PAH treatment (1 μM DMBA/BaP each) induces expression of luciferase driven by Hrk promoter in transient transfection assay using HEK 
cells (*P < 0.01). Activity of the promoter was greatly reduced by mutation of all 3 XRE sites in the presence of vehicle, but no induction occurred 
after PAH exposure using mutated construct. Data are shown as mean ± SEM of 3 independent experiments performed in pentuplicate and are 
expressed as fold change of luciferase/β-galactosidase ratio.
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Regulation of Hrk expression in Bax-deficient mouse ovaries and in human ovarian cortical strips. (A) Induction of Bax expression in ovaries of 
3-week-old littermates exposed to vehicle only or PAH treatment prior to pregnancy and during lactation. While Bax induction was evident in both 
primordial and primary follicles (arrows) in wild-type ovaries upon PAH exposure, induction was not evident in the Hrk-deficient females. Note that 
larger follicles with several layers of granulosa cells also abundantly expressed Bax. However, this expression was regulated by gonadotropins 
and was independent of PAH treatment. Images are representative results of at least 3 different animals/genotype/treatment. (B) Hrk-deficient 
neonatal ovaries failed to upregulate Bax transcript expression in response to in vitro exposure to PAHs over a 24-hour period. The expression 
data are shown as fold change in PAH-treated versus vehicle-treated ovary from the same female (mean ± SEM) and were obtained from 7 
sets of independent ovaries per treatment/genotype. PAH induced a significantly different response between wild-type and Hrk-deficient ovaries 
(P = 0.035). (C) PAHs induce Hrk expression in human primary (set 1) and primordial (set 2) follicles in ex vivo model. Representative images of 
immunohistochemical analysis of Hrk protein levels, evidenced by brown staining, in follicles of ovarian grafts 48 hours after exposure to vehicle, 
PAH, or PAH and resveratrol. Follicles exposed to PAHs have abnormal shrinking morphology typical of degenerating apoptotic follicles. Induction 
of Hrk was observed primarily in the granulosa cells (arrows) as well as in the surrounding stroma and was almost completely abolished in both 
cell types by cotreatment with resveratrol (magnification, ×1,000). Data shown are representative results observed from 2 independent sets of 
experiments using tissues from 2 different patients. No immunoreactivity was observed when primary antibody was omitted (data not shown).
research article













































































































































































































Hrk promoter analysis and site-directed mutagenesis. The mouse Hrk pro-
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